Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Uliv is a healthcare company dedicated to transforming the menopause experience through a comprehensive digital platform that combines clinical care, community support, and evidence-based products. Founded by former executives from Myovant Sciences, the company provides women with direct access to specialized clinical treatment, personalized health plans, and a supportive community to manage the symptoms of perimenopause and menopause. Uliv's approach integrates medical interventions, such as hormone replacement therapy (HRT), with holistic support and educational resources. By leveraging technology and clinical expertise, Uliv aims to close the significant gap in menopause care and provide standardized, high-quality solutions for a historically underserved population.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ULIV.